A previous open study suggested that oral inositol 3 g/day ameliorates
lithium-induced polyuria-polydipsia as rated subjectively by patients
. We designed a double-blind crossover study of 6 g/day oral inositol
versus placebo, each given for 2 weeks, in seven patients. Inositol di
d not reverse lithium-induced polyuria, as measured by 24 h urine volu
me and urine specific gravity. However, subjects' subjective report of
symptomatology was significantly improved on inositol as compared to
placebo, possibly due to alleviation of polydipsia. Inositol was previ
ously shown to reverse lithium-induced polydipsia in rats. Such a phen
omenon may be mediated by either a central or a peripheral mechanism.
In order to study such suggested mechanisms, we injected daily inosito
l or artificial CSF i.c.v. to rats exhibiting lithium-induced polydips
ia. Inositol i.c.v. reversed lithium-induced polydipsia, but kidney in
ositol levels in Li-treated rats were not different from controls. The
se findings suggest that inositol may alleviate symptoms of lithium-in
duced polydipsia via a central effect, but has no direct effect on lit
hium-induced polyuria. (C) 1997 John Wiley & Sons, Ltd.